Verve Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
VERV
CUSIP
92539P101
Type
Equity
Class
COM
Num filings
70
Total reported value, excl. options
$2.25 B
Manager Report Date Value ($000) Shares Option Type